Literature DB >> 12105238

Current prescriptions for the correction of hyponatraemia and hypernatraemia: are they too simple?

Noha R Barsoum1, Barton S Levine.   

Abstract

Hypo- and hypernatraemic (dysnatraemic) disorders are among the most common electrolyte disorders encountered by primary care providers and nephrologists. They represent a diagnostic and therapeutic challenge, and inappropriate management can result in serious sequelae. Several formulas addressing the fluid prescription for dysnatraemic patients have been introduced. Many authors stress the importance of considering output as well as input in formulating a treatment plan for the dysnatraemic patient. However, currently available formulas fail to account for ongoing renal and extrarenal fluid and electrolyte losses. We propose a novel, versatile formula based on established principles governing the distribution of Na(+) in body fluids. The formula can be used in a simplified form for a quick but accurate estimate of the change in serum [Na(+)] for any infused fluid, while simultaneously accounting for renal losses. The formula can also be expanded to include more complex losses if desired. Importantly, it forces the caregiver to consider both output and input when formulating a prescription for the dysnatraemic patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105238     DOI: 10.1093/ndt/17.7.1176

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

1.  Factors associated with mortality in patients presenting to the emergency department with severe hypernatremia.

Authors:  Ihsan Ates; Nihal Özkayar; Güvenç Toprak; Nisbet Yılmaz; Fatih Dede
Journal:  Intern Emerg Med       Date:  2015-12-21       Impact factor: 3.397

Review 2.  Exercise-associated hyponatraemia: a mathematical review.

Authors:  Louise B Weschler
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 3.  Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Authors:  Ewout J Hoorn; Robert Zietse
Journal:  J Am Soc Nephrol       Date:  2017-02-07       Impact factor: 10.121

Review 4.  Improving on the Adrogué-Madias Formula.

Authors:  Sheldon Chen; Michael Shieh; Robert Chiaramonte; Jason Shey
Journal:  Kidney360       Date:  2020-12-04

5.  Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.

Authors:  Manuel Dominguez; Jose A Perez; Chirag B Patel
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 6.  Diagnosis and management of hyponatremia in acute illness.

Authors:  Robert W Schrier; Shweta Bansal
Journal:  Curr Opin Crit Care       Date:  2008-12       Impact factor: 3.687

7.  Effects of Tissue Sodium Storage on Plasma Sodium Concentration in Response to Hypo- and Hypertonic Stimuli.

Authors:  Rosa D Wouda; Rik H G Olde Engberink; Eliane F E Wenstedt; Jetta J Oppelaar; Liffert Vogt
Journal:  Nephron       Date:  2021-06-18       Impact factor: 2.847

8.  Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study.

Authors:  Antoine Roquilly; Pierre Joachim Mahe; Dominique Demeure Dit Latte; Olivier Loutrel; Philippe Champin; Christelle Di Falco; Athanase Courbe; Kevin Buffenoir; Olivier Hamel; Corinne Lejus; Véronique Sebille; Karim Asehnoune
Journal:  Crit Care       Date:  2011-10-28       Impact factor: 9.097

Review 9.  Principles of management of severe hyponatremia.

Authors:  Antonios H Tzamaloukas; Deepak Malhotra; Bradley H Rosen; Dominic S C Raj; Glen H Murata; Joseph I Shapiro
Journal:  J Am Heart Assoc       Date:  2013-01-23       Impact factor: 5.501

10.  Undercorrection of hypernatremia is frequent and associated with mortality.

Authors:  Stanislas Bataille; Camille Baralla; Dominique Torro; Christophe Buffat; Yvon Berland; Marc Alazia; Anderson Loundou; Pierre Michelet; Henri Vacher-Coponat
Journal:  BMC Nephrol       Date:  2014-02-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.